Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

HBI Christmas Special Deals+Insights Briefing, December 2025: Deals+Insights members

Click here to download your 2025 Christmas Special Deals+Insights briefing. The 2025 Christmas bonus special edition covers several major healthcare and life sciences deals: Tertianum, Switzerland’s largest for-profit nursing home group, acquiring Senevita, the Swiss branch of pan-European French group emeis; buyer interest in British supplements company Vitabiotics; London-based private equity firm Bridgepoint’s potential takeover […]

Interview: Neil Daly, Skin Analytics

Skin Analytics is a UK company that has developed an AI-based software tool to analyse whether patients with skin lesions have cancer. In a conversation with HBI, the company’s CEO, Neil Daly, explained how AI tools need to be able to make accurate clinical decisions autonomously, without human input, in order to provide an efficiency benefit to the healthcare system.

Bupa Hong Kong expands coverage to 3,600 hospitals in mainland China

Bupa Hong Kong, the Chinese division of multinational health insurer and provider Bupa, is massively expanding its coverage in mainland China, with a new scheme covering 3,600 hospitals across the country. The company is simultaneously expanding coverage to 3,000 ‘service points’ on the island of Hong Kong.

UK care sector draws strong interest from global private equity

2025 was a busy year for the care sector, with lots of M&A deals either happening, planned, or being considered. Activity has risen sharply and the market is currently at a high point. HBI spoke with Amar Shah, Partner, and Vikas Sharma, Director, both in Healthcare and Life Sciences M&A at Deloitte UK, about trends in the UK social care market, including investment flows, valuations, staffing, technology and expectations for 2026.

PAI Partners to buy Innovad Group

French private equity firm PAI Partners is set to buy Belgium based Innovad Group, which makes animal health and nutrition products, from London-based IK Partners’ IK IX Fund.

Bridgepoint eyes takeover of AMS, maker of surgical products

London-based private-equity firm Bridgepoint is reportedly considering a takeover of UK-listed Advanced Medical Solutions (AMS), which makes surgical products such as adhesives, sutures, haemostats, and internal sealants under brands LiquiBand and RESORBA. HBI reached out to both Bridgepoint and AMS. Both companies declined to comment although neither denied the reports.

Find Us